There is a newer version
of
this Section
2017 Georgia Code
Title 31 - Health
Chapter 52 - Terminally Ill Patient's Right to Try Investigational Drugs, Biological Products, and Devices
§ 31-52-4. Eligibility criteria
Universal Citation: GA Code § 31-52-4 (2017)
- In order for a person to be considered an eligible patient to access an investigational drug, biological product, or device pursuant to this chapter, a physician must document in writing that the person:
- (1) Has a terminal illness;
- (2) Has, in consultation with the physician, considered all other treatment options currently approved by the federal Food and Drug Administration;
- (3) Has been given a recommendation by the physician for an investigational drug, biological product, or device; and
- (4) Has given written informed consent for the use of the investigational drug, biological product, or device.
Disclaimer: These codes may not be the most recent version. Georgia may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
